Adding MDSC to co-cultures of T-cell and AML cells resulted in reduced AML-blast killing, while the addition of an IDO inhibitor promoted the AMG 330-mediated clearance of AML-blasts. The gene discussed is IDO1; the disease is acute myeloid leukemia.